Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Rigel

Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data

Arvinas (NASDAQ:ARVN) management outlined a more selective development strategy at a Jefferies-hosted investor discussion, emphasizing internal investment in neurological and oncology programs where the company believes it can create differentiated therapies, while seeking partners for assets that m

PMET Commences 2026 Summer-Fall Drill Campaign at the Shaakichiuwaanaan Property

MONTREAL, May 21, 2026 /PRNewswire/ -- May 21, 2026 – Sydney, Australia HIGHLIGHTSMajor 2026 summer-fall exploration campaign underway at the Shaakichiuwaanaan Property in Québec, Canada, comprising approximately 45,000 m of drilling.The Shaakichiuwaanaan Camp has successfully reopened ahead of schedule, with critical restart activities now completed and exploration teams progressively remobilizing…

Arvinas Q1 Earnings Call Highlights

Arvinas (NASDAQ:ARVN) said its first quarter was marked by the FDA approval of VEPPANU, a new licensing agreement with Rigel Pharmaceuticals and continued progress across a clinical-stage pipeline focused on targeted protein degradation. President and Chief Executive Officer Randy Teel said the app

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This ‘Darling’ Pharma Stock Is Hitting New Highs

Rigel Pharmaceuticals (RIGL) is showing exceptional momentum, setting new 52-week highs on Aug. 22. Shares are up nearly 243% over the past year. The stock is trading above key moving averages and is supported by several “Strong Buy” analyst ratings. Fundamentals show impressive projected earnings growth this year, but both...

Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.

Nasdaq Drops 150 Points; AZZ Shares Plummet

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday.

Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939.

inkl

Read news from The Economist, FT, and more,
with one subscription

Dow Surges Over 100 Points; Crude Oil Down 2%

Dow Surges Over 100 Points; Crude Oil Down 2%

U.S. stocks pared some losses midway through trading, with the Dow Jones gaining more than 100 points on Tuesday.

Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial

Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial

Rigel Pharmaceuticals Inc (NASDAQ: RIGL) shares are falling on disappointing data from the FORWARD Phase 3 trial of fostamatinib in patients with warm autoimmune hemolytic anemia (wAIHA).

Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America

Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America

Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)

1

People

Jim Van Meerten

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Department of Labor

Rigel Pharmaceuticals

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

397,087 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play